Global Burosumab Market Research Report 2024(Status and Outlook)
Report Overview
Burosumab , a fully human IgG1 monoclonal antibody directed at fibroblast growth factor 23 (FGF23), is indicated for the treatment of X-linked hypophosphatemia (XLH), a condition associated with excessive FGF23 production.
This report provides a deep insight into the global Burosumab market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Burosumab Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Burosumab market in any manner.
Global Burosumab Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Ultragenyx
Kyowa Kirin
Market Segmentation (by Type)
10mg/mL
20mg/mL
30mg/mL
Market Segmentation (by Application)
Minor Patients Over 1 Year Old
Adult Patients
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Burosumab Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Burosumab , a fully human IgG1 monoclonal antibody directed at fibroblast growth factor 23 (FGF23), is indicated for the treatment of X-linked hypophosphatemia (XLH), a condition associated with excessive FGF23 production.
This report provides a deep insight into the global Burosumab market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Burosumab Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Burosumab market in any manner.
Global Burosumab Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Ultragenyx
Kyowa Kirin
Market Segmentation (by Type)
10mg/mL
20mg/mL
30mg/mL
Market Segmentation (by Application)
Minor Patients Over 1 Year Old
Adult Patients
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Burosumab Market
- Overview of the regional outlook of the Burosumab Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Burosumab Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Burosumab
1.2 Key Market Segments
1.2.1 Burosumab Segment by Type
1.2.2 Burosumab Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BUROSUMAB MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Burosumab Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Burosumab Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BUROSUMAB MARKET COMPETITIVE LANDSCAPE
3.1 Global Burosumab Sales by Manufacturers (2019-2024)
3.2 Global Burosumab Revenue Market Share by Manufacturers (2019-2024)
3.3 Burosumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Burosumab Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Burosumab Sales Sites, Area Served, Product Type
3.6 Burosumab Market Competitive Situation and Trends
3.6.1 Burosumab Market Concentration Rate
3.6.2 Global 5 and 10 Largest Burosumab Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BUROSUMAB INDUSTRY CHAIN ANALYSIS
4.1 Burosumab Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BUROSUMAB MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BUROSUMAB MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Burosumab Sales Market Share by Type (2019-2024)
6.3 Global Burosumab Market Size Market Share by Type (2019-2024)
6.4 Global Burosumab Price by Type (2019-2024)
7 BUROSUMAB MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Burosumab Market Sales by Application (2019-2024)
7.3 Global Burosumab Market Size (M USD) by Application (2019-2024)
7.4 Global Burosumab Sales Growth Rate by Application (2019-2024)
8 BUROSUMAB MARKET SEGMENTATION BY REGION
8.1 Global Burosumab Sales by Region
8.1.1 Global Burosumab Sales by Region
8.1.2 Global Burosumab Sales Market Share by Region
8.2 North America
8.2.1 North America Burosumab Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Burosumab Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Burosumab Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Burosumab Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Burosumab Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Ultragenyx
9.1.1 Ultragenyx Burosumab Basic Information
9.1.2 Ultragenyx Burosumab Product Overview
9.1.3 Ultragenyx Burosumab Product Market Performance
9.1.4 Ultragenyx Business Overview
9.1.5 Ultragenyx Burosumab SWOT Analysis
9.1.6 Ultragenyx Recent Developments
9.2 Kyowa Kirin
9.2.1 Kyowa Kirin Burosumab Basic Information
9.2.2 Kyowa Kirin Burosumab Product Overview
9.2.3 Kyowa Kirin Burosumab Product Market Performance
9.2.4 Kyowa Kirin Business Overview
9.2.5 Kyowa Kirin Burosumab SWOT Analysis
9.2.6 Kyowa Kirin Recent Developments
10 BUROSUMAB MARKET FORECAST BY REGION
10.1 Global Burosumab Market Size Forecast
10.2 Global Burosumab Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Burosumab Market Size Forecast by Country
10.2.3 Asia Pacific Burosumab Market Size Forecast by Region
10.2.4 South America Burosumab Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Burosumab by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Burosumab Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Burosumab by Type (2025-2030)
11.1.2 Global Burosumab Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Burosumab by Type (2025-2030)
11.2 Global Burosumab Market Forecast by Application (2025-2030)
11.2.1 Global Burosumab Sales (Kilotons) Forecast by Application
11.2.2 Global Burosumab Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Burosumab
1.2 Key Market Segments
1.2.1 Burosumab Segment by Type
1.2.2 Burosumab Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BUROSUMAB MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Burosumab Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Burosumab Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BUROSUMAB MARKET COMPETITIVE LANDSCAPE
3.1 Global Burosumab Sales by Manufacturers (2019-2024)
3.2 Global Burosumab Revenue Market Share by Manufacturers (2019-2024)
3.3 Burosumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Burosumab Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Burosumab Sales Sites, Area Served, Product Type
3.6 Burosumab Market Competitive Situation and Trends
3.6.1 Burosumab Market Concentration Rate
3.6.2 Global 5 and 10 Largest Burosumab Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BUROSUMAB INDUSTRY CHAIN ANALYSIS
4.1 Burosumab Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BUROSUMAB MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BUROSUMAB MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Burosumab Sales Market Share by Type (2019-2024)
6.3 Global Burosumab Market Size Market Share by Type (2019-2024)
6.4 Global Burosumab Price by Type (2019-2024)
7 BUROSUMAB MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Burosumab Market Sales by Application (2019-2024)
7.3 Global Burosumab Market Size (M USD) by Application (2019-2024)
7.4 Global Burosumab Sales Growth Rate by Application (2019-2024)
8 BUROSUMAB MARKET SEGMENTATION BY REGION
8.1 Global Burosumab Sales by Region
8.1.1 Global Burosumab Sales by Region
8.1.2 Global Burosumab Sales Market Share by Region
8.2 North America
8.2.1 North America Burosumab Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Burosumab Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Burosumab Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Burosumab Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Burosumab Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Ultragenyx
9.1.1 Ultragenyx Burosumab Basic Information
9.1.2 Ultragenyx Burosumab Product Overview
9.1.3 Ultragenyx Burosumab Product Market Performance
9.1.4 Ultragenyx Business Overview
9.1.5 Ultragenyx Burosumab SWOT Analysis
9.1.6 Ultragenyx Recent Developments
9.2 Kyowa Kirin
9.2.1 Kyowa Kirin Burosumab Basic Information
9.2.2 Kyowa Kirin Burosumab Product Overview
9.2.3 Kyowa Kirin Burosumab Product Market Performance
9.2.4 Kyowa Kirin Business Overview
9.2.5 Kyowa Kirin Burosumab SWOT Analysis
9.2.6 Kyowa Kirin Recent Developments
10 BUROSUMAB MARKET FORECAST BY REGION
10.1 Global Burosumab Market Size Forecast
10.2 Global Burosumab Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Burosumab Market Size Forecast by Country
10.2.3 Asia Pacific Burosumab Market Size Forecast by Region
10.2.4 South America Burosumab Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Burosumab by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Burosumab Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Burosumab by Type (2025-2030)
11.1.2 Global Burosumab Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Burosumab by Type (2025-2030)
11.2 Global Burosumab Market Forecast by Application (2025-2030)
11.2.1 Global Burosumab Sales (Kilotons) Forecast by Application
11.2.2 Global Burosumab Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Burosumab Market Size Comparison by Region (M USD)
Table 5. Global Burosumab Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Burosumab Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Burosumab Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Burosumab Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Burosumab as of 2022)
Table 10. Global Market Burosumab Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Burosumab Sales Sites and Area Served
Table 12. Manufacturers Burosumab Product Type
Table 13. Global Burosumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Burosumab
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Burosumab Market Challenges
Table 22. Global Burosumab Sales by Type (Kilotons)
Table 23. Global Burosumab Market Size by Type (M USD)
Table 24. Global Burosumab Sales (Kilotons) by Type (2019-2024)
Table 25. Global Burosumab Sales Market Share by Type (2019-2024)
Table 26. Global Burosumab Market Size (M USD) by Type (2019-2024)
Table 27. Global Burosumab Market Size Share by Type (2019-2024)
Table 28. Global Burosumab Price (USD/Ton) by Type (2019-2024)
Table 29. Global Burosumab Sales (Kilotons) by Application
Table 30. Global Burosumab Market Size by Application
Table 31. Global Burosumab Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Burosumab Sales Market Share by Application (2019-2024)
Table 33. Global Burosumab Sales by Application (2019-2024) & (M USD)
Table 34. Global Burosumab Market Share by Application (2019-2024)
Table 35. Global Burosumab Sales Growth Rate by Application (2019-2024)
Table 36. Global Burosumab Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Burosumab Sales Market Share by Region (2019-2024)
Table 38. North America Burosumab Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Burosumab Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Burosumab Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Burosumab Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Burosumab Sales by Region (2019-2024) & (Kilotons)
Table 43. Ultragenyx Burosumab Basic Information
Table 44. Ultragenyx Burosumab Product Overview
Table 45. Ultragenyx Burosumab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Ultragenyx Business Overview
Table 47. Ultragenyx Burosumab SWOT Analysis
Table 48. Ultragenyx Recent Developments
Table 49. Kyowa Kirin Burosumab Basic Information
Table 50. Kyowa Kirin Burosumab Product Overview
Table 51. Kyowa Kirin Burosumab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Kyowa Kirin Business Overview
Table 53. Kyowa Kirin Burosumab SWOT Analysis
Table 54. Kyowa Kirin Recent Developments
Table 55. Global Burosumab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Global Burosumab Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. North America Burosumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. North America Burosumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Europe Burosumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 60. Europe Burosumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Asia Pacific Burosumab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 62. Asia Pacific Burosumab Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. South America Burosumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 64. South America Burosumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Middle East and Africa Burosumab Consumption Forecast by Country (2025-2030) & (Units)
Table 66. Middle East and Africa Burosumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Global Burosumab Sales Forecast by Type (2025-2030) & (Kilotons)
Table 68. Global Burosumab Market Size Forecast by Type (2025-2030) & (M USD)
Table 69. Global Burosumab Price Forecast by Type (2025-2030) & (USD/Ton)
Table 70. Global Burosumab Sales (Kilotons) Forecast by Application (2025-2030)
Table 71. Global Burosumab Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Burosumab Market Size Comparison by Region (M USD)
Table 5. Global Burosumab Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Burosumab Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Burosumab Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Burosumab Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Burosumab as of 2022)
Table 10. Global Market Burosumab Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Burosumab Sales Sites and Area Served
Table 12. Manufacturers Burosumab Product Type
Table 13. Global Burosumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Burosumab
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Burosumab Market Challenges
Table 22. Global Burosumab Sales by Type (Kilotons)
Table 23. Global Burosumab Market Size by Type (M USD)
Table 24. Global Burosumab Sales (Kilotons) by Type (2019-2024)
Table 25. Global Burosumab Sales Market Share by Type (2019-2024)
Table 26. Global Burosumab Market Size (M USD) by Type (2019-2024)
Table 27. Global Burosumab Market Size Share by Type (2019-2024)
Table 28. Global Burosumab Price (USD/Ton) by Type (2019-2024)
Table 29. Global Burosumab Sales (Kilotons) by Application
Table 30. Global Burosumab Market Size by Application
Table 31. Global Burosumab Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Burosumab Sales Market Share by Application (2019-2024)
Table 33. Global Burosumab Sales by Application (2019-2024) & (M USD)
Table 34. Global Burosumab Market Share by Application (2019-2024)
Table 35. Global Burosumab Sales Growth Rate by Application (2019-2024)
Table 36. Global Burosumab Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Burosumab Sales Market Share by Region (2019-2024)
Table 38. North America Burosumab Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Burosumab Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Burosumab Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Burosumab Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Burosumab Sales by Region (2019-2024) & (Kilotons)
Table 43. Ultragenyx Burosumab Basic Information
Table 44. Ultragenyx Burosumab Product Overview
Table 45. Ultragenyx Burosumab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Ultragenyx Business Overview
Table 47. Ultragenyx Burosumab SWOT Analysis
Table 48. Ultragenyx Recent Developments
Table 49. Kyowa Kirin Burosumab Basic Information
Table 50. Kyowa Kirin Burosumab Product Overview
Table 51. Kyowa Kirin Burosumab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Kyowa Kirin Business Overview
Table 53. Kyowa Kirin Burosumab SWOT Analysis
Table 54. Kyowa Kirin Recent Developments
Table 55. Global Burosumab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Global Burosumab Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. North America Burosumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. North America Burosumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Europe Burosumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 60. Europe Burosumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Asia Pacific Burosumab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 62. Asia Pacific Burosumab Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. South America Burosumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 64. South America Burosumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Middle East and Africa Burosumab Consumption Forecast by Country (2025-2030) & (Units)
Table 66. Middle East and Africa Burosumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Global Burosumab Sales Forecast by Type (2025-2030) & (Kilotons)
Table 68. Global Burosumab Market Size Forecast by Type (2025-2030) & (M USD)
Table 69. Global Burosumab Price Forecast by Type (2025-2030) & (USD/Ton)
Table 70. Global Burosumab Sales (Kilotons) Forecast by Application (2025-2030)
Table 71. Global Burosumab Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Burosumab
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Burosumab Market Size (M USD), 2019-2030
Figure 5. Global Burosumab Market Size (M USD) (2019-2030)
Figure 6. Global Burosumab Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Burosumab Market Size by Country (M USD)
Figure 11. Burosumab Sales Share by Manufacturers in 2023
Figure 12. Global Burosumab Revenue Share by Manufacturers in 2023
Figure 13. Burosumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Burosumab Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Burosumab Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Burosumab Market Share by Type
Figure 18. Sales Market Share of Burosumab by Type (2019-2024)
Figure 19. Sales Market Share of Burosumab by Type in 2023
Figure 20. Market Size Share of Burosumab by Type (2019-2024)
Figure 21. Market Size Market Share of Burosumab by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Burosumab Market Share by Application
Figure 24. Global Burosumab Sales Market Share by Application (2019-2024)
Figure 25. Global Burosumab Sales Market Share by Application in 2023
Figure 26. Global Burosumab Market Share by Application (2019-2024)
Figure 27. Global Burosumab Market Share by Application in 2023
Figure 28. Global Burosumab Sales Growth Rate by Application (2019-2024)
Figure 29. Global Burosumab Sales Market Share by Region (2019-2024)
Figure 30. North America Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Burosumab Sales Market Share by Country in 2023
Figure 32. U.S. Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Burosumab Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Burosumab Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Burosumab Sales Market Share by Country in 2023
Figure 37. Germany Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Burosumab Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Burosumab Sales Market Share by Region in 2023
Figure 44. China Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Burosumab Sales and Growth Rate (Kilotons)
Figure 50. South America Burosumab Sales Market Share by Country in 2023
Figure 51. Brazil Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Burosumab Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Burosumab Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Burosumab Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Burosumab Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Burosumab Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Burosumab Market Share Forecast by Type (2025-2030)
Figure 65. Global Burosumab Sales Forecast by Application (2025-2030)
Figure 66. Global Burosumab Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Burosumab
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Burosumab Market Size (M USD), 2019-2030
Figure 5. Global Burosumab Market Size (M USD) (2019-2030)
Figure 6. Global Burosumab Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Burosumab Market Size by Country (M USD)
Figure 11. Burosumab Sales Share by Manufacturers in 2023
Figure 12. Global Burosumab Revenue Share by Manufacturers in 2023
Figure 13. Burosumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Burosumab Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Burosumab Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Burosumab Market Share by Type
Figure 18. Sales Market Share of Burosumab by Type (2019-2024)
Figure 19. Sales Market Share of Burosumab by Type in 2023
Figure 20. Market Size Share of Burosumab by Type (2019-2024)
Figure 21. Market Size Market Share of Burosumab by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Burosumab Market Share by Application
Figure 24. Global Burosumab Sales Market Share by Application (2019-2024)
Figure 25. Global Burosumab Sales Market Share by Application in 2023
Figure 26. Global Burosumab Market Share by Application (2019-2024)
Figure 27. Global Burosumab Market Share by Application in 2023
Figure 28. Global Burosumab Sales Growth Rate by Application (2019-2024)
Figure 29. Global Burosumab Sales Market Share by Region (2019-2024)
Figure 30. North America Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Burosumab Sales Market Share by Country in 2023
Figure 32. U.S. Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Burosumab Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Burosumab Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Burosumab Sales Market Share by Country in 2023
Figure 37. Germany Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Burosumab Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Burosumab Sales Market Share by Region in 2023
Figure 44. China Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Burosumab Sales and Growth Rate (Kilotons)
Figure 50. South America Burosumab Sales Market Share by Country in 2023
Figure 51. Brazil Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Burosumab Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Burosumab Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Burosumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Burosumab Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Burosumab Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Burosumab Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Burosumab Market Share Forecast by Type (2025-2030)
Figure 65. Global Burosumab Sales Forecast by Application (2025-2030)
Figure 66. Global Burosumab Market Share Forecast by Application (2025-2030)
